Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Stacking CJC-1295 Ipamorelin Sleep Optimization: Protocol Comparison

CJC-1295 Only 1–2mg weekly None Weekly Minimal (GH pulses occur but lack amplitude) 10–15% Insufficient for sleep optimization—GHRH alone doesn't trigger strong enough nocturnal pulses Ipamorelin Only 200–300mcg nightly Nightly Moderate (15–20 min reduction) 2

This comparison does not assign a generated winner or score.

  • CJC-1295 Only
  • 1–2mg weekly
  • None
  • Weekly
  • Minimal (GH pulses occur but lack amplitude)
  • 10–15%
  • Insufficient for sleep optimization—GHRH alone doesn't trigger strong enough nocturnal pulses
  • Ipamorelin Only
  • 200–300mcg nightly
  • Nightly
  • Moderate (15–20 min reduction)
  • 25–30%
  • Better than baseline but lacks duration—GH pulses are sharp but short-lived
  • CJC + Ipamorelin Stack
  • CJC weekly, Ipamorelin nightly
  • Significant (20–30 min reduction)
  • 40–60%
  • Optimal synergy—extended pulse duration + increased amplitude = measurable deep sleep improvement
  • High-Dose Ipamorelin
  • 500mcg+ nightly
  • Variable (can worsen with receptor desensitisation)
  • 20–35% initially, declines over 4–6 weeks
  • Receptor downregulation negates benefits—higher doses don't improve outcomes
More references

Related material